Pancreatobiliary Carcinoma — Trials

Pancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,131 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 699
Recruiting: 403
Ph III recruiting: 36
Growth YoY: +23.4%
Industry share: 30%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (303)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02600949	Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer	enrolling by invitation	Phase 1	300	M.D. Anderson Cancer CenterOTHER	1	Jun 17, 2026	clinicaltrials
NCT01868490	The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells	enrolling by invitation	Phase 1 / Phase 2	20	Siriraj HospitalOTHER	1	Feb 10, 2025	clinicaltrials